Press office news tagged school-of-biomedical-sciences
-
University researchers to tackle drug-resistant disease that jumps from pigs to humans
Dr Michael Jarvis's The Vaccine Group and Professor Mat Upton have received £700,000 funding from the Department of Health and Social Care (DHSC) to tackle a disease which can cause meningitis, blood poisoning, or septicaemia.
-
Research to identify and target high blood pressure indicators
High blood pressure, or hypertension, is a leading cause of stroke and heart attacks worldwide – and one in four people have it. New research led by the University of Plymouth could identify how to target this condition and other blood vessel problems.
-
University spin-out company to develop new antibiotics
New University of Plymouth spinout company Amprologix has been established to help tackle the problem of antibiotic resistance – by developing new antibiotics and bringing them to market. It is led by Professor Mat Upton in collaboration with Frontier IP
-
Research grant to develop vaccine for mastitis in cows
University spinout company The Vaccine Group (TVG), led by Dr Michael Jarvis, has received £50,000 from the global Bacterial Vaccine Network (“BactiVac”) and will use the grant to run a proof-of-concept study